News and Announcements
Manufacturing Serendipity: The Art of Taking Your Business from Unknown to Known
- Published June 08, 2023 4:00AM UTC
- Publisher Wholesale Investor
- Categories Capital Raising Tips
As a founder, your ultimate goal is to make your business known, whether it is for attracting clients, staff, or investors. But how can people buy from you, work for you, or invest in you if they don’t know about you? This is where manufacturing serendipity comes in.
In the world of capital raising, your job is to create opportunities for chance encounters that could potentially change the trajectory of your business.
However, it is important to understand the psychology behind this process. You need to meet a lot of people to find the right one, and it only takes one person to make a significant impact on your business.
In this video, we dive deep into the art of manufacturing serendipity and discuss the different ways you can build awareness in your capital raise. We also provide actionable tips to help you improve your chances of meeting the right people and making meaningful connections. Don’t miss out on the power of serendipity in your capital raise!
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
